Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066393
Filing Date
2025-05-08
Accepted
2025-05-08 07:30:23
Documents
70
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rapp-20250331.htm   iXBRL 10-Q 2569669
2 EX-10.1 rapp-ex10_1.htm EX-10.1 89130
3 EX-31.1 rapp-ex31_1.htm EX-31.1 17550
4 EX-31.2 rapp-ex31_2.htm EX-31.2 16934
5 EX-32.1 rapp-ex32_1.htm EX-32.1 15889
  Complete submission text file 0000950170-25-066393.txt   9574228

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rapp-20250331.xsd EX-101.SCH 1267007
73 EXTRACTED XBRL INSTANCE DOCUMENT rapp-20250331_htm.xml XML 1596421
Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Filer) CIK: 0002012593 (see all company filings)

EIN.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42121 | Film No.: 25923886
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)